Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 33,893,810 | 33,893,810 | - | - | Class C Common Stock | |
| TWFG Inc (Class A) | Michael Doak | Director | Other type of transaction at price $ 0.00 per share. | 17 Jul 2024 | 1,820,234 | 1,820,234 | - | - | Class B Common Stock | |
| TWFG Inc (Class A) | Michael Doak | Director | Other type of transaction at price $ 0.00 per share. | 17 Jul 2024 | 1,820,234 | 0 | - | - | Class B LLC Units in TWFG Holding Company, LLC | |
| TWFG Inc (Class A) | Michael Doak | Director | Other type of transaction at price $ 0.00 per share. | 17 Jul 2024 | 1,820,234 | 1,820,234 | - | - | Class B LLC Units in TWFG Holding Company, LLC | |
| Nauticus Robotics Inc | William H. Flores | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 1,062,003 | 1,062,003 | - | - | Restricted Stock Units | |
| Nauticus Robotics Inc | Elliot Spiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 910,288 | 910,288 | - | - | Restricted Stock Units | |
| Nauticus Robotics Inc | Jim Bellingham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 910,288 | 910,288 | - | - | Restricted Stock Units | |
| Nauticus Robotics Inc | Adam Sharkawy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 910,288 | 910,288 | - | - | Restricted Stock Units | |
| TWFG Inc (Class A) | Michael Doak | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 588,235 | 591,764 | - | 17 | 9,999,995 | Class A Common Stock |
| Fluent Inc | Matthew Conlin | Director, Chief Customer Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 487,589 | 1,601,164 (2%) | 0% | 0.0 | 244 | Common Stock |
| Fluent Inc | Matthew Conlin | Director, Chief Customer Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 487,589 | 0 | - | - | Pre-Funded Warrant | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 342,362 | 33,893,810 | - | - | LLC Units in TWFG Holding Company, LLC | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 342,262 | 492,949 | - | - | Class A Common Stock | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 282,845 | 513,099 (0%) | 0% | 175 | 49,497,875 | Common Stock, $0.01 par value | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 211,622 | 211,622 | - | - | Performance Right | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 207,693 | 207,693 | - | - | Non-Qualified Stock Option (right to buy) | |
| Morgan Stanley | James P. Gorman | Director, Executive Chairman | 17 Jul 2024 | 200,000 | 150,000 (0%) | 0% | 105.1 | 21,012,300 | Common Stock | |
| Morgan Stanley | Edward N. Pick | Director, Chief Executive Officer | Other type of transaction at price $ 106.12 per share. | 17 Jul 2024 | 200,000 | 801,407 (0%) | 0% | 106.1 | 21,224,000 | Common Stock |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 185,426 | 684,225 | - | 17 | 3,152,242 | Class A Common Stock |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 147,058 | 150,687 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Richard F. Bunch III | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 135,205 | 135,205 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 135,205 | 135,205 | - | 0 | Class A Common Stock | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 119,418 | 59,709 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 119,418 | 719,567 (0%) | 0% | 79.0 | 9,436,410 | Common Stock, $0.01 par value | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 105,811 | 644,877 (1%) | 0% | 0 | Common Stock | |
| Coursera Inc | Andrew Y. Ng | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Coursera Inc | Andrew Y. Ng | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 17 Jul 2024 | 100,000 | 7,228,892 | - | 1.7 | 168,000 | Common Stock |
| Toast Inc (Class A) | Christopher P. Comparato | Director | 17 Jul 2024 | 90,000 | 202,282 | - | 1.5 | 136,800 | Class A Common Stock | |
| Toast Inc (Class A) | Christopher P. Comparato | Director | 17 Jul 2024 | 90,000 | 620,000 | - | - | Stock Option (Right to Buy) | ||
| TWFG Inc (Class A) | Katherine C. Nolan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 88,235 | 88,235 | - | 0 | Class A Common Stock | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 87,050 | 600,149 (0%) | 0% | 61.4 | 5,341,388 | Common Stock, $0.01 par value | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 87,050 | 0 | - | - | Option (Right To Buy) | ||
| Toast Inc (Class A) | Christopher P. Comparato | Director | 17 Jul 2024 | 85,900 | 116,382 | - | 26.5 | 2,277,810 | Class A Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 77,905 | 77,905 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 76,458 | 76,458 | - | - | Non-Qualified Stock Option (right to buy) | |
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 76,377 | 152,755 | - | - | Option (Right To Buy) | ||
| AbbVie | Richard A. Gonzalez | Director, EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | 76,377 | 795,944 (0%) | 0% | 93.5 | 7,141,250 | Common Stock, $0.01 par value | |
| Fluent Inc | Matthew Conlin | Director, Chief Customer Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 73,877 | 125,039 (0%) | 0% | 0.0 | 37 | Common Stock |
| Fluent Inc | Matthew Conlin | Director, Chief Customer Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 73,877 | 0 | - | - | Pre-Funded Warrant | |
| NewAmsterdam Pharma Co NV | Mark C. McKenna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 72,500 | 72,500 | - | - | Option (right to buy) | |
| TWFG Inc (Class A) | Janice E. Zwinggi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 58,823 | 58,823 | - | 0 | Class A Common Stock | |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 56,279 | 690,312 (1%) | 0% | 0 | Common Stock | |
| Socket Mobile Inc | Kevin J. Mills | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 55,000 | 145,207 (2%) | 0% | 0 | Common Stock | |
| Nurix Therapeutics Inc | Lori Anne Kunkel | Director | 17 Jul 2024 | 54,027 | 0 | - | 0 | Common Stock | ||
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 52,378 | 0 | - | - | Performance Right | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 118.48 per share. | 17 Jul 2024 | 50,730 | 78,712,754 (12%) | 0% | 118.5 | 6,010,607 | Common Stock |
| TWFG Inc (Class A) | Charles Alexander Bunch | Chf Creative & Marketing Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 47,058 | 47,058 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Julie E. Benes | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 47,058 | 47,058 | - | 0 | Class A Common Stock | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 120.45 per share. | 17 Jul 2024 | 46,075 | 78,551,310 (12%) | 0% | 120.5 | 5,549,932 | Common Stock |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 44,042 | 453,287 | - | 10.0 | 440,433 | Common Stock |
| Morgan Stanley | Daniel A. Simkowitz | Co-President | Sale of securities on an exchange or to another person at price $ 106.54 per share. | 17 Jul 2024 | 40,000 | 442,522 (0%) | 0% | 106.5 | 4,261,768 | Common Stock |
| QuinStreet Inc | Gregory Wong | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 17 Jul 2024 | 40,000 | 330,139 (0%) | 0% | 4.0 | 160,400 | Common Stock |
| QuinStreet Inc | Gregory Wong | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 40,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Papa Johns International | Ravi Thanawala | Interim CEO, and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 39,607 | 39,607 | - | - | Performance-based Restricted Stock Units | |
| Alignment Healthcare Inc | Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 39,305 | 1,853,629 | - | 10 | 393,050 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 38,953 | 167,854 (0%) | 0% | 0 | Common Stock | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 38,858 | 414,429 | - | 10.0 | 388,790 | Common Stock |
| Ribbon Communications Inc | Lopez A. Miguel | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 38,724 | 38,723 | - | - | Restricted Stock Units (RSU) | |
| Ribbon Communications Inc | A. Lopez Miguel | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 38,724 | 432,348 (0%) | 0% | - | Common Stock | |
| Climb Bio Inc | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 17 Jul 2024 | 38,576 | 160,523 | - | 6.9 | 267,332 | Common Stock |
| Alignment Healthcare Inc | Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 36,700 | 1,816,097 | - | 10.0 | 367,209 | Common Stock |
| BJ`s Wholesale Club Holdings Inc | William C. Werner | EVP, Strategy & Development | Sale of securities on an exchange or to another person at price $ 90.93 per share. | 17 Jul 2024 | 33,437 | 33,034 (0%) | 0% | 90.9 | 3,040,426 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 119.44 per share. | 17 Jul 2024 | 33,137 | 78,679,617 (12%) | 0% | 119.4 | 3,957,936 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 119.55 per share. | 17 Jul 2024 | 30,773 | 78,597,385 (12%) | 0% | 119.6 | 3,679,057 | Common Stock |
| Angiodynamic Inc | Laura Piccinini | SVP International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 30,428 | 30,428 | - | - | Performance Right | |
| Angiodynamic Inc | Laura Piccinini | SVP International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 29,863 | 29,863 | - | - | Non-Qualified Stock Option (right to buy) | |
| Fluent Inc | Donald Patrick | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 29,551 | 0 | - | - | Pre-Funded Warrant | |
| Fluent Inc | Donald Patrick | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 29,551 | 349,313 (0%) | 0% | 0.0 | 15 | Common Stock |
| Angiodynamic Inc | James C. Clemmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 28,730 | 661,582 (1%) | 0% | 7.4 | 212,602 | Common Stock |
| Papa Johns International | Caroline Miller Oyler | Chief Legal & Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 27,725 | 27,725 | - | - | Performance-based Restricted Stock Units | |
| Shoals Tech Grp Inc (Class A) | Brandon Moss | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.81 per share. | 17 Jul 2024 | 27,639 | 218,270 | - | 6.8 | 188,222 | Class A Common Stock |
| BJ`s Wholesale Club Holdings Inc | William C. Werner | EVP, Strategy & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 17 Jul 2024 | 25,315 | 66,471 (0%) | 0% | 17 | 430,355 | Common Stock |
| BJ`s Wholesale Club Holdings Inc | William C. Werner | EVP, Strategy & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 25,315 | 20,000 | - | - | Stock Option | |
| McCormick & Company | Lawrence E. Kurzius | Director | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 17 Jul 2024 | 25,000 | 0 (0%) | 0% | 75 | 1,875,000 | Common Stock - Non Voting |
| Charles Schwab | Walter W. Bettinger | Director, Co-Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 66.26 per share. | 17 Jul 2024 | 25,000 | 827,377 (0%) | 0% | 66.3 | 1,656,500 | Common Stock |
| Alignment Healthcare Inc | Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 24,900 | 1,208,321 | - | 10 | 249,000 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 24,699 | 24,699 | - | - | Performance Right | |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 24,240 | 24,240 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 23,952 | 23,952 | - | - | Performance Right | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 23,507 | 23,507 | - | - | Non-Qualified Stock Option (right to buy) | |
| Alignment Healthcare Inc | Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 23,163 | 1,892,934 | - | 10.0 | 231,642 | Common Stock |
| ThredUp Inc (Class A) | Alon Rotem | Chief Legal Officer | 17 Jul 2024 | 23,042 | 218,348 | - | 2.0 | 46,261 | Class A Common Stock | |
| Candel Therapeutics Inc | Tak Peter Paul | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 22,528 | 330,735 | - | 6.5 | 145,815 | Common Stock |
| Aptevo Therapeutics Inc | Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 22,325 | 22,325 | - | - | Restricted Stock Unit | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 17 Jul 2024 | 22,100 | 497,329 | - | 10.0 | 221,013 | Common Stock |
| Angiodynamic Inc | Laura Piccinini | SVP International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 21,971 | 41,064 (0%) | 0% | 0 | Common Stock | |
| Puma biotech Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 17 Jul 2024 | 21,920 | 7,063,515 (17%) | 0% | 3.7 | 81,128 | Common Stock |
| Capital One | Robert M. Alexander | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 21,347 | 0 | - | - | Stock Options | |
| Capital One | Robert M. Alexander | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.34 per share. | 17 Jul 2024 | 21,347 | 104,476 (0%) | 0% | 86.3 | 1,843,100 | Common Stock |
| Capital One | Robert M. Alexander | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 17 Jul 2024 | 21,347 | 83,129 (0%) | 0% | 150 | 3,202,050 | Common Stock |
| Angiodynamic Inc | Eileen O'Shea Auen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 87,043 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 149,376 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Wesley E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 125,863 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Jan Stern Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 87,359 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 65,703 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Karen A. Licitra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 72,760 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 37,582 (0%) | 0% | 0 | Common Stock | |
| Coca-Cola | Nancy Quan | Executive Vice President | Sale of securities on an exchange or to another person at price $ 64.96 per share. | 17 Jul 2024 | 19,304 | 223,330 (0%) | 0% | 65.0 | 1,253,901 | Common Stock, $.25 Par Value |
| Coca-Cola | Nancy Quan | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 19,304 | 19,305 | - | - | Employee Stock Option (Right to Buy) | |
| Coca-Cola | Nancy Quan | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.89 per share. | 17 Jul 2024 | 19,304 | 242,634 (0%) | 0% | 40.9 | 789,341 | Common Stock, $.25 Par Value |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 18,733 | 42,261 (0%) | 0% | 0 | Common Stock | |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jul 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.40 per share. | 17 Jul 2024 | 17,500 | 220,937 (0%) | 0% | 51.4 | 899,500 | Common Stock |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 17,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 17,500 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 17 Jul 2024 | 17,500 | 238,437 (0%) | 0% | 3.0 | 52,850 | Common Stock |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.55 per share. | 17 Jul 2024 | 17,500 | 220,937 (0%) | 0% | 51.6 | 902,125 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 118.51 per share. | 17 Jul 2024 | 17,314 | 78,628,158 (12%) | 0% | 118.5 | 2,051,841 | Common Stock |
| TWFG Inc (Class A) | Robin A. Ferracone | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 16,000 | 19,529 | - | 17 | 272,000 | Class A Common Stock |
| Ribbon Communications Inc | Lopez Miguel A. | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.90 per share. | 17 Jul 2024 | 15,237 | 417,111 (0%) | 0% | 3.9 | 59,424 | Common Stock |
| FedEx | Sriram Krishnasamy | EVP CDI Off & CTO/CEO FDW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 15,000 | 15,000 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Tyagarajan Seshu | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,851 | 146,049 | - | 6.5 | 96,125 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 14,817 | 0 | - | - | Performance Right | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 121.34 per share. | 17 Jul 2024 | 14,717 | 78,536,593 (12%) | 0% | 121.3 | 1,785,733 | Common Stock |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Sale of securities on an exchange or to another person at price $ 34.50 per share. | 17 Jul 2024 | 14,315 | 164,723 (0%) | 0% | 34.5 | 493,868 | Common Stock, par value $0.001 per share |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,051 | 159,961 | - | 6.5 | 90,947 | Common Stock |
| Aptevo Therapeutics Inc | Jeffrey G. Lamothe | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 12,825 | 12,825 | - | - | Restricted Stock Unit | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 120.67 per share. | 17 Jul 2024 | 12,559 | 78,667,058 (12%) | 0% | 120.7 | 1,515,505 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 182.49 per share. | 17 Jul 2024 | 12,351 | 2,215,034 (0%) | 0% | 182.5 | 2,253,946 | Class C Capital Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 12,350 | 65,366 (0%) | 0% | 0 | Common Stock | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 121.23 per share. | 17 Jul 2024 | 12,063 | 78,654,995 (12%) | 0% | 121.2 | 1,462,439 | Common Stock |
| Midland States Bancorp Inc | Douglas J. Tucker | SVP Corporate Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 11,566 | 0 | - | - | Option (right to buy) | |
| Midland States Bancorp Inc | Douglas J. Tucker | SVP Corporate Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.00 per share. | 17 Jul 2024 | 11,566 | 44,437 (0%) | 0% | 23 | 266,018 | Common Stock |
| VF Corp | Bracken Darrell | Director, President & Chief Exec Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.59 per share. | 17 Jul 2024 | 11,490 | 208,999 (0%) | 0% | 15.6 | 179,129 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 11,142 | 177,612 (0%) | 0% | 0 | Common Stock | |
| Kratos Defense & Security Soln Inc | Scott I. Anderson | Director | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 17 Jul 2024 | 11,000 | 90,735 (0%) | 0% | 21.8 | 239,632 | Common Stock |
| Candel Therapeutics Inc | Garrett Nichols William | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 10,875 | 114,482 | - | 6.5 | 70,390 | Common Stock |
| Midland States Bancorp Inc | Douglas J. Tucker | SVP Corporate Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.40 per share. | 17 Jul 2024 | 10,796 | 33,641 (0%) | 0% | 25.4 | 274,218 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 117.72 per share. | 17 Jul 2024 | 10,711 | 78,763,484 (12%) | 0% | 117.7 | 1,260,897 | Common Stock |
| ThredUp Inc (Class A) | James Reinhart | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 17 Jul 2024 | 10,600 | 841,249 | - | 2.0 | 21,223 | Class A Common Stock |
| Brixmor Property Grp Inc | Steven F. Siegel | See remarks | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 17 Jul 2024 | 10,000 | 350,004 (0%) | 0% | 24.5 | 245,000 | Common Stock |
| Asana Inc (Class A) | Tim M. Wan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Jul 2024 | 10,000 | 1,050,284 | - | 15 | 150,000 | Class A Common Stock |
| Asana Inc (Class A) | Tim M. Wan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 17 Jul 2024 | 10,000 | 1,060,284 | - | 1.6 | 16,000 | Class A Common Stock |
| Asana Inc (Class A) | Tim M. Wan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 10,000 | 710,899 | - | - | Stock Option (right to buy) | |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 17 Jul 2024 | 10,000 | 1,715,193 (6%) | 0% | 31.1 | 310,500 | Common Stock |
| Charles Schwab | Richard A. Wurster | President | Purchase of securities on an exchange or from another person at price $ 62.05 per share. | 17 Jul 2024 | 10,000 | 144,228 (0%) | 0% | 62.0 | 620,454 | Common Stock |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.28 per share. | 17 Jul 2024 | 10,000 | 132,009 (0%) | 0% | 11.3 | 112,750 | Common Stock |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 10,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Sonos Inc | Chris Mason | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 17 Jul 2024 | 10,000 | 122,009 (0%) | 0% | 14.5 | 144,500 | Common Stock |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 9,884 | 62,520 | - | 6.5 | 63,975 | Common Stock |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 11.25 per share. | 17 Jul 2024 | 9,585 | 5,454,558 | - | 11.2 | 107,831 | Class A Common Stock |
| Capital One | Robert M. Alexander | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 17 Jul 2024 | 9,395 | 73,734 (0%) | 0% | 150 | 1,409,250 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 183.14 per share. | 17 Jul 2024 | 9,149 | 2,205,885 (0%) | 0% | 183.1 | 1,675,534 | Class C Capital Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 203.34 per share. | 17 Jul 2024 | 9,000 | 927,582 (2%) | 0% | 203.3 | 1,830,060 | Common Stock |
| DXC Tech Co | Robert F. Del Bene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 17 Jul 2024 | 8,944 | 185,251 (0%) | 0% | 19.8 | 176,823 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 8,777 | 0 | - | - | Performance Right | |
| Aptevo Therapeutics Inc | Daphne L. Taylor | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 8,550 | 8,550 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | So Young Kwon | SVP, GC, BD & Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 8,550 | 8,550 | - | - | Restricted Stock Unit | |
| Immunovant Inc | Peter Salzmann | Director, Chief Executive Officer | 17 Jul 2024 | 8,175 | 1,023,922 (1%) | 0% | 29.6 | 242,307 | Common Stock | |
| DXC Tech Co | Robert F. Del Bene | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 17 Jul 2024 | 7,940 | 194,195 (0%) | 0% | 19.8 | 156,974 | Common Stock |
| IDT Corp (Class B) | Joyce J. Mason | EVP and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 37.25 per share. | 17 Jul 2024 | 7,570 | 12,996 (0%) | 0% | 37.3 | 281,993 | Class B Common Stock, par value $.01 per share |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 7,550 | 0 | - | - | Performance Right | |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 123.82 per share. | 17 Jul 2024 | 6,699 | 2,254,715 (0%) | 0% | 123.8 | 829,478 | Common Stock |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 6,600 | 70,187 (0%) | 0% | 0 | Common Stock | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 11.17 per share. | 17 Jul 2024 | 6,439 | 5,443,953 | - | 11.2 | 71,924 | Class A Common Stock |
| TWFG Inc (Class A) | Katherine C. Nolan | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 6,250 | 94,485 | - | 17 | 106,250 | Class A Common Stock |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 87.19 per share. | 17 Jul 2024 | 6,085 | 49,313 (0%) | 0% | 87.2 | 530,572 | Common Shares, par value $0.18 |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 117.59 per share. | 17 Jul 2024 | 6,082 | 78,645,472 (12%) | 0% | 117.6 | 715,199 | Common Stock |
| Angiodynamic Inc | Laura Piccinini | SVP International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 5,903 | 0 | - | - | Performance Right | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 5,850 | 695,925 | - | 17 | 99,450 | Class A Common Stock |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 5,850 | 498,799 | - | 17 | 99,450 | Class A Common Stock |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 5,850 | 690,075 | - | 17 | 99,450 | Class A Common Stock |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 5,677 | 46,675 (0%) | 0% | 0 | Common Stock | |
| FedEx | Krishnasamy Sriram | EVP CDI Off & CTO/CEO FDW | Sale of securities on an exchange or to another person at price $ 310.32 per share. | 17 Jul 2024 | 5,627 | 15,040 (0%) | 0% | 310.3 | 1,746,171 | Common Stock |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 17 Jul 2024 | 5,496 | 221,840 | - | 42 | 230,832 | Class A Common Stock |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 85.81 per share. | 17 Jul 2024 | 5,400 | 38,498 (0%) | 0% | 85.8 | 463,396 | Common Shares, par value $0.18 |
| MSC Industrial Direct Co. Inc (Class A) | Kimberly Shacklett | SVP, Sales & Customer Success | Sale of securities on an exchange or to another person at price $ 84.60 per share. | 17 Jul 2024 | 4,885 | 12,897 (0%) | 0% | 84.6 | 413,251 | Class A Common Stock, $0.001 par value |
| MSC Industrial Direct Co. Inc (Class A) | Kimberly Shacklett | SVP, Sales & Customer Success | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.60 per share. | 17 Jul 2024 | 4,885 | 17,782 (0%) | 0% | 79.6 | 388,846 | Class A Common Stock, $0.001 par value |
| MSC Industrial Direct Co. Inc (Class A) | Kimberly Shacklett | SVP, Sales & Customer Success | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 4,885 | 0 | - | - | Options (right to buy) | |
| RideNow Grp Inc (Class B) | Mark Cohen | Director, Member of a 10% Group | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 4,882 | 0 (0%) | 0% | - | Class B Common Stock | |
| RideNow Grp Inc (Class B) | Mark Cohen | Director, Member of a 10% Group | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 4,882 | 6,409,139 (14%) | 0% | - | Class B Common Stock | |
| Angiodynamic Inc | Laura Piccinini | SVP International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 4,439 | 42,491 (0%) | 0% | 0 | Common Stock | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 11.13 per share. | 17 Jul 2024 | 4,166 | 5,450,392 | - | 11.1 | 46,368 | Class A Common Stock |
| Puma biotech Inc | Maximo F. Nougues | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 17 Jul 2024 | 4,156 | 162,522 (0%) | 0% | 3.7 | 15,382 | Common Stock |
| Toast Inc (Class A) | Christopher P. Comparato | Director | 17 Jul 2024 | 4,100 | 112,282 | - | 27.1 | 111,069 | Class A Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 4,016 | 173,596 (0%) | 0% | 7.4 | 29,718 | Common Stock |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | 17 Jul 2024 | 4,000 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 4,000 | 4,000 | - | - | Class B Common Stock | |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 4,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | 17 Jul 2024 | 4,000 | 227,336 | - | - | Class A Common Stock | ||
| FedEx | Sriram Krishnasamy | EVP CDI Off & CTO/CEO FDW | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,855 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| FedEx | Sriram Krishnasamy | EVP CDI Off & CTO/CEO FDW | Exercise or conversion of derivative security received from the company (such as an option) at price $ 130.96 per share. | 17 Jul 2024 | 3,855 | 20,667 (0%) | 0% | 131.0 | 504,851 | Common Stock |
| Universal Display Corp | Richard C. Elias | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 3,823 | 7,793 (0%) | 0% | 0 | Common Stock | |
| Universal Display Corp | Richard C. Elias | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 3,823 | 9,503 (0%) | 0% | 0 | Common Stock | |
| CoStar | Christopher J. Nassetta | Director | 17 Jul 2024 | 3,781 | 231,396 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| CoStar | Michael R. Klein | Director | 17 Jul 2024 | 3,781 | 1,991,006 (5%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| CoStar | John W. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,689 | 20,234 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Puma biotech Inc | Douglas M. Hunt | See Remarks | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 17 Jul 2024 | 3,637 | 133,227 (0%) | 0% | 3.7 | 13,461 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,600 | 97,469 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,600 | 93,869 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 17 Jul 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 129.49 per share. | 17 Jul 2024 | 3,600 | 3,730 (0%) | 0% | 129.5 | 466,164 | Common Stock |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,537 | 3,537 (0%) | 0% | - | Common Stock | |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 3,537 | 7,073 | - | - | Restricted Stock Units | |
| TWFG Inc (Class A) | Robin A. Ferracone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,529 | 3,529 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Michael Doak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,529 | 3,529 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Janet S. Wong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,529 | 3,529 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Jonathan Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,529 | 3,529 | - | 0 | Class A Common Stock | |
| TWFG Inc (Class A) | Michelle Caroline Bunch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,529 | 3,629 | - | 0 | Class A Common Stock | |
| QCR Holding Inc | Larry J. Helling | Director, CEO, QCRH & CRBT | 17 Jul 2024 | 3,500 | 40,235 (0%) | 0% | 17.5 | 61,215 | Common Stock | |
| QCR Holding Inc | Larry J. Helling | Director, CEO, QCRH & CRBT | 17 Jul 2024 | 3,500 | 3,215 | - | - | Non-Qualified Stock Option (right to buy) | ||
| CoStar | Louise S. Sams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,491 | 16,118 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| CoStar | Angelique G. Brunner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,491 | 7,023 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| CoStar | Laura Cox Kaplan | Director | 17 Jul 2024 | 3,452 | 17,835 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 116.83 per share. | 17 Jul 2024 | 3,441 | 78,651,554 (12%) | 0% | 116.8 | 401,998 | Common Stock |
| Fiserv | Jennifer A. LaClair | EVP, Head of GBS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.96 per share. | 17 Jul 2024 | 3,310 | 26,304 (0%) | 0% | 158.0 | 522,848 | Common Stock |
| CoStar | Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 3,293 | 15,156 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Universal Display Corp | Richard C. Elias | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 3,280 | 11,616 (0%) | 0% | 0 | Common Stock | |
| Universal Display Corp | Richard C. Elias | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 3,280 | 628 (0%) | 0% | 0 | Common Stock | |
| Climb Bio Inc | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 17 Jul 2024 | 3,207 | 199,099 | - | 6.9 | 22,160 | Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 180.40 per share. | 17 Jul 2024 | 3,060 | 418,184 (0%) | 0% | 180.4 | 552,037 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 180.40 per share. | 17 Jul 2024 | 3,059 | 414,043 (0%) | 0% | 180.4 | 551,856 | Class A Common Stock |
| Stitch Fix Inc (Class A) | OConnor Casey | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 17 Jul 2024 | 3,045 | 447,175 (0%) | 0% | 5.0 | 15,103 | Class A Common Stock |
| TWFG Inc (Class A) | Janice E. Zwinggi | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 3,000 | 61,823 | - | 17 | 51,000 | Class A Common Stock |
| Hippo Holdings Inc | Rick Mccathron | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 20.00 per share. | 17 Jul 2024 | 2,998 | 393,290 | - | 20 | 59,960 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Jul 2024 | 2,939 | 347,728 (0%) | 0% | 29.6 | 87,112 | Common Stock | |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 87.95 per share. | 17 Jul 2024 | 2,915 | 46,398 (0%) | 0% | 88.0 | 256,382 | Common Shares, par value $0.18 |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 122.86 per share. | 17 Jul 2024 | 2,900 | 2,261,414 (0%) | 0% | 122.9 | 356,298 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 200.28 per share. | 17 Jul 2024 | 2,900 | 939,682 (2%) | 0% | 200.3 | 580,812 | Common Stock |
| Unitedhealth Grp | Thomas E. Roos | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 569.88 per share. | 17 Jul 2024 | 2,851 | 29,501 (0%) | 0% | 569.9 | 1,624,734 | Common Stock |
| FedEx | Krishnasamy Sriram | EVP CDI Off & CTO/CEO FDW | Sale of securities on an exchange or to another person at price $ 309.79 per share. | 17 Jul 2024 | 2,794 | 12,246 (0%) | 0% | 309.8 | 865,547 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.42 per share. | 17 Jul 2024 | 2,780 | 417,102 (0%) | 0% | 179.4 | 498,785 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.42 per share. | 17 Jul 2024 | 2,780 | 414,042 (0%) | 0% | 179.4 | 498,785 | Class A Common Stock |
| Pricesmart Inc | Jeffrey R. Fisher | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 17 Jul 2024 | 2,776 | 27,124 (0%) | 0% | 90 | 249,840 | Common Stock, $0.0001 par value per share |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Jul 2024 | 2,698 | 444,155 (0%) | 0% | 29.6 | 79,969 | Common Stock | |
| DigitalOcean Holdings Inc | Bratin Saha | Chief Product & Tech Officer | 17 Jul 2024 | 2,694 | 419,302 | - | 34.7 | 93,536 | Common Stock | |
| Richardson Electronics Ltd | Wendy S. Diddell | Director, COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 17 Jul 2024 | 2,691 | 100,964 (0%) | 0% | 12.5 | 33,503 | Common Stock |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 120.86 per share. | 17 Jul 2024 | 2,601 | 2,266,414 (0%) | 0% | 120.9 | 314,347 | Common Stock |
| Puma biotech Inc | Jeffrey Jerome Ludwig | Chief Commercial Officer | 17 Jul 2024 | 2,598 | 118,388 (0%) | 0% | 3.7 | 9,615 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 17 Jul 2024 | 2,585 | 171,011 (0%) | 0% | 7.2 | 18,560 | Common Stock |
| Unifirst Corp | William M. Ross | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 2,530 | 6,564 (0%) | 0% | 0 | Common Stock | |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 84.82 per share. | 17 Jul 2024 | 2,500 | 43,898 (0%) | 0% | 84.8 | 212,062 | Common Shares, par value $0.18 |
| TWFG Inc (Class A) | Janet S. Wong | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 2,500 | 6,029 | - | 17 | 42,500 | Class A Common Stock |
| Angiodynamic Inc | Laura Piccinini | SVP International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 2,485 | 40,006 (0%) | 0% | 7.4 | 18,389 | Common Stock |
| Gitlab Inc (Class A) | Robin J. Schulman | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 56.25 per share. | 17 Jul 2024 | 2,402 | 142,933 | - | 56.3 | 135,113 | Class A Common Stock |
| ProFrac Holding Corp (Class A) | Steven Scrogham | CLO, CCO & Corp. Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.57 per share. | 17 Jul 2024 | 2,380 | 52,848 | - | 8.6 | 20,397 | Class A common stock, par value $0.01 per share |
| Angiodynamic Inc | Chad Thomas Campbell | SVP/GM, Vascular Access | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 2,379 | 67,808 (0%) | 0% | 7.4 | 17,605 | Common Stock |
| Immunovant Inc | William L. Macias | Chief Medical Officer | 17 Jul 2024 | 2,362 | 372,041 (0%) | 0% | 29.6 | 70,010 | Common Stock | |
| Immunovant Inc | Mark S. Levine | Chief Legal Officer | 17 Jul 2024 | 2,358 | 337,556 (0%) | 0% | 29.6 | 69,891 | Common Stock | |
| Unifirst Corp | William M. Ross | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 182.53 per share. | 17 Jul 2024 | 2,305 | 4,259 (0%) | 0% | 182.5 | 420,732 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Michael A. Colglazier | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 2,273 | 43,141 (0%) | 0% | 0 | Common Stock | |
| Virgin Galactic Holdings Inc (Class A) | Michael A. Colglazier | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 2,273 | 25,000 | - | - | Restricted Stock Units | |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 202.51 per share. | 17 Jul 2024 | 2,200 | 936,582 (2%) | 0% | 202.5 | 445,522 | Common Stock |
| Progressive | Philip Bleser | Director | Sale of securities on an exchange or to another person at price $ 219.08 per share. | 17 Jul 2024 | 2,129 | 974 (0%) | 0% | 219.1 | 466,421 | Common |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 121.57 per share. | 17 Jul 2024 | 2,100 | 2,264,314 (0%) | 0% | 121.6 | 255,297 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 6.77 per share. | 17 Jul 2024 | 2,000 | 18,469 (0%) | 0% | 6.8 | 13,540 | Common Stock |
| Pagerduty Inc | Jennifer G. Tejada | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 17 Jul 2024 | 2,000 | 1,015,637 (1%) | 0% | 22 | 44,000 | Common Stock |
| Sturm, Ruger & Co. Inc | F. Sarah Colbert | VP of Administration | Sale of securities on an exchange or to another person at price $ 45.14 per share. | 17 Jul 2024 | 2,000 | 32,080 (0%) | 0% | 45.1 | 90,280 | Common Stock |
| Hippo Holdings Inc | Rick Mccathron | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 20.18 per share. | 17 Jul 2024 | 1,999 | 391,291 | - | 20.2 | 40,334 | Common Stock |
| Voya Fin Inc | William J. Mullaney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 1,965 | 1,965 | - | - | Restricted Stock Units | |
| Palomar Holdings Inc | Jon Christianson | President | Sale of securities on an exchange or to another person at price $ 91.31 per share. | 17 Jul 2024 | 1,900 | 51,861 (0%) | 0% | 91.3 | 173,492 | Common Stock |
| Accel Entertainment Inc (Class A1) | David W. Ruttenberg | Director | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 17 Jul 2024 | 1,801 | 569,453 (32%) | 0% | 10.5 | 18,921 | Class A-1 Common Stock |
| Accel Entertainment Inc (Class A1) | David W. Ruttenberg | Director | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 17 Jul 2024 | 1,800 | 429,554 (24%) | 0% | 10.5 | 18,911 | Class A-1 Common Stock |
| FedEx | Krishnasamy Sriram | EVP CDI Off & CTO/CEO FDW | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,772 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| FedEx | Krishnasamy Sriram | EVP CDI Off & CTO/CEO FDW | Exercise or conversion of derivative security received from the company (such as an option) at price $ 161.85 per share. | 17 Jul 2024 | 1,772 | 16,812 (0%) | 0% | 161.8 | 286,798 | Common Stock |
| QCR Holding Inc | Larry J. Helling | Director, CEO, QCRH & CRBT | 17 Jul 2024 | 1,679 | 38,556 (0%) | 0% | 69.0 | 115,901 | Common Stock | |
| Angiodynamic Inc | Warren G. Nighan | SVP Quality and Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 1,666 | 45,009 (0%) | 0% | 7.4 | 12,328 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 122.12 per share. | 17 Jul 2024 | 1,598 | 78,534,995 (12%) | 0% | 122.1 | 195,152 | Common Stock |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | 17 Jul 2024 | 1,496 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,496 | 1,496 | - | - | Class B Common Stock | |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,496 | 48,504 | - | - | Stock Option (Right to Buy) | |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | 17 Jul 2024 | 1,496 | 223,336 | - | - | Class A Common Stock | ||
| Virgin Galactic Holdings Inc (Class A) | Douglas T. Ahrens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,377 | 28,923 (0%) | 0% | 0 | Common Stock | |
| Virgin Galactic Holdings Inc (Class A) | Douglas T. Ahrens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,377 | 15,144 | - | - | Restricted Stock Units | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 181.30 per share. | 17 Jul 2024 | 1,362 | 419,882 (0%) | 0% | 181.3 | 246,935 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 181.30 per share. | 17 Jul 2024 | 1,362 | 416,822 (0%) | 0% | 181.3 | 246,935 | Class A Common Stock |
| Unifirst Corp | William M. Ross | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,297 | 0 | - | - | Stock Appreciation Right | |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,271 | 2,542 | - | - | Restricted Stock Units | |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,271 | 3,756 (0%) | 0% | - | Common Stock | |
| Encore Cap Grp Inc | Andrew E. Asch | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 17 Jul 2024 | 1,251 | 18,075 (0%) | 0% | 50 | 62,550 | Common Stock |
| Weyco Grp Inc | Allison Woss | VP - SUPPLY CHAIN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.94 per share. | 17 Jul 2024 | 1,250 | 7,075 (0%) | 0% | 27.9 | 34,925 | Common Stock |
| Weyco Grp Inc | Allison Woss | VP - SUPPLY CHAIN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,250 | 1,250 | - | - | Stock Option | |
| Movado Grp Inc | Michelle Kennedy | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 26.05 per share. | 17 Jul 2024 | 1,245 | 12,202 (0%) | 0% | 26.0 | 32,432 | Common Stock |
| Unifirst Corp | William M. Ross | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,233 | 0 | - | - | Stock Appreciation Right | |
| Virgin Galactic Holdings Inc (Class A) | Michael A. Colglazier | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 1,222 | 41,919 (0%) | 0% | 8.0 | 9,825 | Common Stock |
| Pagerduty Inc | Jennifer G. Tejada | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,200 | 954,034 | - | - | Stock Option (Right to Buy) | |
| Pagerduty Inc | Jennifer G. Tejada | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 17 Jul 2024 | 1,200 | 1,017,637 (1%) | 0% | 2 | 2,400 | Common Stock |
| Walt Disney | Brent A. Woodford | EVP, Control, Fin Plan & Tax | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,179 | 4,715 | - | - | Restricted Stock Unit | |
| Walt Disney | Brent A. Woodford | EVP, Control, Fin Plan & Tax | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,179 | 44,343 (0%) | 0% | - | Disney Common Stock | |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.76 per share. | 17 Jul 2024 | 1,174 | 3,591,068 (6%) | 0% | 160.8 | 188,732 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.76 per share. | 17 Jul 2024 | 1,174 | 3,013,977 (5%) | 0% | 160.8 | 188,732 | Common Stock |
| Walt Disney | Sonia L. Coleman | Sr. EVP and Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,155 | 3,384 (0%) | 0% | - | Disney Common Stock | |
| Walt Disney | Sonia L. Coleman | Sr. EVP and Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,155 | 4,619 | - | - | Restricted Stock Unit | |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.49 per share. | 17 Jul 2024 | 1,052 | 2,485 (0%) | 0% | 114.5 | 120,443 | Common Stock |
| Jack Henry & Associates | Mimi L. Carsley | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,052 | 2,625 (0%) | 0% | - | Common Stock | |
| Jack Henry & Associates | Mimi L. Carsley | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,052 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 333.50 per share. | 17 Jul 2024 | 1,051 | 1,647 (0%) | 0% | 333.5 | 350,507 | Common Stock |
| PPG Industries | Kathy Lynn Fortmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 1,041 | 1,041 | - | - | Restricted Stock Units | |
| Weyco Grp Inc | Allison Woss | VP - SUPPLY CHAIN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.67 per share. | 17 Jul 2024 | 1,038 | 6,037 (0%) | 0% | 33.7 | 34,949 | Common Stock |
| Richardson Electronics Ltd | Edward J. Richardson | Director, Chairman & CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 17 Jul 2024 | 1,038 | 40,263 (0%) | 0% | 12.4 | 12,923 | Common Stock |
| Moog Inc (Class A) | Paul Wilkinson | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.38 per share. | 17 Jul 2024 | 1,000 | 1,036 (0%) | 0% | 74.4 | 74,380 | Class A Common |
| Moog Inc (Class A) | Paul Wilkinson | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,000 | 0 | - | - | SAR | |
| RenaissanceRe Holdings Ltd | David Marra | EVP,Chief Underwriting Officer | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 17 Jul 2024 | 1,000 | 85,544 (0%) | 0% | 230 | 230,000 | Common Stock |
| Intercontinental Exchange | Christopher Scott Edmonds | President, Fixed Income & Data | Sale of securities on an exchange or to another person at price $ 148.60 per share. | 17 Jul 2024 | 1,000 | 14,636 (0%) | 0% | 148.6 | 148,600 | Common Stock |
| Palomar Holdings Inc | T. Christopher Uchida | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 1,000 | 2,156 | - | - | Employee Stock Option (Right to Buy) | |
| Palomar Holdings Inc | T. Christopher Uchida | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 17 Jul 2024 | 1,000 | 25,094 (0%) | 0% | 15 | 15,000 | Common Stock |
| TWFG Inc (Class A) | Charles Alexander Bunch | Chf Creative & Marketing Off | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 1,000 | 48,058 | - | 17 | 17,000 | Class A Common Stock |
| TWFG Inc (Class A) | Julie E. Benes | General Counsel and Secretary | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Jul 2024 | 1,000 | 48,058 | - | 17 | 17,000 | Class A Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.32 per share. | 17 Jul 2024 | 1,000 | 2,204,885 (0%) | 0% | 184.3 | 184,323 | Class C Capital Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 330.17 per share. | 17 Jul 2024 | 997 | 2,488 (0%) | 0% | 330.2 | 329,177 | Common Stock |
| Palomar Holdings Inc | T. Christopher Uchida | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.26 per share. | 17 Jul 2024 | 950 | 24,144 (0%) | 0% | 91.3 | 86,699 | Common Stock |
| Aptevo Therapeutics Inc | Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Esperion Therapeutics Inc | JoAnne Micale Foody | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 17 Jul 2024 | 917 | 272,862 (0%) | 0% | 2.6 | 2,383 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 201.50 per share. | 17 Jul 2024 | 900 | 938,782 (2%) | 0% | 201.5 | 181,350 | Common Stock |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 86.76 per share. | 17 Jul 2024 | 900 | 37,598 (0%) | 0% | 86.8 | 78,087 | Common Shares, par value $0.18 |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 334.53 per share. | 17 Jul 2024 | 883 | 764 (0%) | 0% | 334.5 | 295,386 | Common Stock |
| Morgan Stanley | Robert H. Herz | Director | Sale of securities on an exchange or to another person at price $ 106.62 per share. | 17 Jul 2024 | 861 | 96,046 (0%) | 0% | 106.6 | 91,800 | Common Stock |
| Alignment Healthcare Inc | Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 832 | 1,852,797 | - | 10.0 | 8,328 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 332.68 per share. | 17 Jul 2024 | 810 | 2,698 (0%) | 0% | 332.7 | 269,467 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 116.90 per share. | 17 Jul 2024 | 800 | 78,774,195 (12%) | 0% | 116.9 | 93,522 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Michael A. Colglazier | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 797 | 41,122 (0%) | 0% | 8.0 | 6,408 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 332.59 per share. | 17 Jul 2024 | 795 | 911 (0%) | 0% | 332.6 | 264,410 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 331.60 per share. | 17 Jul 2024 | 782 | 1,706 (0%) | 0% | 331.6 | 259,308 | Common Stock |
| FedEx | Krishnasamy Sriram | EVP CDI Off & CTO/CEO FDW | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 781 | 15,040 (0%) | 0% | 0 | Common Stock | |
| Paychex | Joseph G. Doody | Director | Other type of transaction at price $ 0.00 per share. | 17 Jul 2024 | 765 | 22,997 (0%) | 0% | 0 | Common Stock - Family Trust | |
| Paychex | Joseph G. Doody | Director | Other type of transaction at price $ 0.00 per share. | 17 Jul 2024 | 765 | 761 (0%) | 0% | 0 | Common Stock | |
| Constellation Brands (Class A) | Christopher J. Baldwin | Director, Non-Exec Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Jennifer M. Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Judy A. Schmeling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Richard Sands | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Robert Sands | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | William T. Giles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Daniel Mccarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Nicholas I. Fink | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Ernesto M. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Luca Zaramella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Christy Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Constellation Brands (Class A) | Jose Manuel Madero Garza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 734 | 734 | - | - | Non-Qualified Stock Option (right to buy) | |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 124.61 per share. | 17 Jul 2024 | 700 | 2,254,015 (0%) | 0% | 124.6 | 87,230 | Common Stock |
| Moog Inc (Class A) | Paul Wilkinson | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.00 per share. | 17 Jul 2024 | 667 | 369 (0%) | 0% | 195 | 130,065 | Class A Common |
| Sezzle Inc | Paul M. Purcell | Former Director | Sale of securities on an exchange or to another person at price $ 92.02 per share. | 17 Jul 2024 | 600 | 353,781 | - | 92.0 | 55,215 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 182.38 per share. | 17 Jul 2024 | 597 | 413,296 (0%) | 0% | 182.4 | 108,881 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 182.38 per share. | 17 Jul 2024 | 596 | 413,296 (0%) | 0% | 182.4 | 108,699 | Class A Common Stock |
| Walt Disney | Sonia L. Coleman | Sr. EVP and Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.57 per share. | 17 Jul 2024 | 586 | 2,798 (0%) | 0% | 97.6 | 57,176 | Disney Common Stock |
| California Water Service Grp | Thomas Krummel | Director | Sale of securities on an exchange or to another person at price $ 52.99 per share. | 17 Jul 2024 | 555 | 23,616 (0%) | 0% | 53.0 | 29,409 | Common Stock |
| Richardson Electronics Ltd | Kathleen M. McNally | EVP Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.45 per share. | 17 Jul 2024 | 532 | 38,115 (0%) | 0% | 12.4 | 6,623 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Aparna Chitale | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 525 | 5,769 | - | - | Restricted Stock Units | |
| Virgin Galactic Holdings Inc (Class A) | Aparna Chitale | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 525 | 10,688 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Peter Salzmann | Director, Chief Executive Officer | 17 Jul 2024 | 510 | 1,023,412 (1%) | 0% | 30.6 | 15,581 | Common Stock | |
| Immunovant Inc | William L. Macias | Chief Medical Officer | 17 Jul 2024 | 504 | 371,390 (0%) | 0% | 29.6 | 14,939 | Common Stock | |
| Constellation Brands (Class A) | Christopher J. Baldwin | Director, Non-Exec Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Jennifer M. Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Judy A. Schmeling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Richard Sands | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Robert Sands | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | William T. Giles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Daniel Mccarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Nicholas I. Fink | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Ernesto M. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Luca Zaramella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Christy Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| Constellation Brands (Class A) | Jose Manuel Madero Garza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 503 | 503 | - | - | Restricted Stock Units | |
| LM Funding America Inc | Ryan Duran | Vice President of Operations | Sale of securities on an exchange or to another person at price $ 4.81 per share. | 17 Jul 2024 | 500 | 18,318 (0%) | 0% | 4.8 | 2,405 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 335.36 per share. | 17 Jul 2024 | 485 | 279 (0%) | 0% | 335.4 | 162,652 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 333.52 per share. | 17 Jul 2024 | 472 | 439 (0%) | 0% | 333.5 | 157,423 | Common Stock |
| Unitedhealth Grp | Thomas E. Roos | Chief Accounting Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jul 2024 | 439 | 29,062 (0%) | 0% | 0 | Common Stock | |
| Virgin Galactic Holdings Inc (Class A) | Douglas T. Ahrens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 423 | 28,500 (0%) | 0% | 8.0 | 3,401 | Common Stock |
| FMC Corp | Brian P. Angeli | Ex. VP & Chief Marketing Off. | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 17 Jul 2024 | 400 | 5,879 (0%) | 0% | 60 | 24,000 | Common Stock |
| Bluelinx Hldgs Inc | Andrew Wamser | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.49 per share. | 17 Jul 2024 | 378 | 3,378 (0%) | 0% | 114.5 | 43,277 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.06 per share. | 17 Jul 2024 | 357 | 3,592,242 (6%) | 0% | 160.1 | 57,141 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 160.06 per share. | 17 Jul 2024 | 357 | 3,015,151 (5%) | 0% | 160.1 | 57,141 | Common Stock |
| Jack Henry & Associates | Mimi L. Carsley | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.74 per share. | 17 Jul 2024 | 341 | 2,284 (0%) | 0% | 169.7 | 57,881 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 334.75 per share. | 17 Jul 2024 | 309 | 130 (0%) | 0% | 334.7 | 103,437 | Common Stock |
| ThredUp Inc (Class A) | Alon Rotem | Chief Legal Officer | 17 Jul 2024 | 300 | 218,048 | - | 2.0 | 609 | Class A Common Stock | |
| Walt Disney | Brent A. Woodford | EVP, Control, Fin Plan & Tax | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.57 per share. | 17 Jul 2024 | 288 | 44,055 (0%) | 0% | 97.6 | 28,100 | Disney Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Aparna Chitale | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 283 | 10,405 (0%) | 0% | 8.0 | 2,275 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 158.68 per share. | 17 Jul 2024 | 250 | 3,015,508 (5%) | 0% | 158.7 | 39,670 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 158.68 per share. | 17 Jul 2024 | 250 | 3,592,599 (6%) | 0% | 158.7 | 39,670 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 329.32 per share. | 17 Jul 2024 | 245 | 3,485 (0%) | 0% | 329.3 | 80,684 | Common Stock |
| Unifirst Corp | William M. Ross | Executive Vice President | Sale of securities on an exchange or to another person at price $ 180.67 per share. | 17 Jul 2024 | 225 | 4,034 (0%) | 0% | 180.7 | 40,651 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Douglas T. Ahrens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 223 | 28,259 (0%) | 0% | 8.0 | 1,793 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Michael A. Colglazier | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 219 | 40,903 (0%) | 0% | 8.0 | 1,761 | Common Stock |
| Unifirst Corp | Cecilia K. McKenney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 219 | 219 | - | - | Stock Appreciation Right( | |
| PPG Industries | Kathy Lynn Fortmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 208 | 208 | - | - | Phantom Stock Units | |
| Signet Jewelers Ltd | Oded Edelman | See Remarks | Sale of securities on an exchange or to another person at price $ 87.54 per share. | 17 Jul 2024 | 200 | 37,398 (0%) | 0% | 87.5 | 17,509 | Common Shares, par value $0.18 |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Jul 2024 | 184 | 347,544 (0%) | 0% | 30.5 | 5,621 | Common Stock | |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 17 Jul 2024 | 175 | 24,650 (0%) | 0% | 31.1 | 5,434 | Common Stock |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 17 Jul 2024 | 175 | 24,650 (0%) | 0% | 31.1 | 5,434 | Common Stock |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 17 Jul 2024 | 175 | 24,650 (0%) | 0% | 31.1 | 5,434 | Common Stock |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 17 Jul 2024 | 175 | 24,650 (0%) | 0% | 31.1 | 5,434 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Jul 2024 | 169 | 443,986 (0%) | 0% | 30.6 | 5,163 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 328.10 per share. | 17 Jul 2024 | 168 | 3,562 (0%) | 0% | 328.1 | 55,121 | Common Stock |
| Virgin Galactic Holdings Inc (Class A) | Aparna Chitale | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 153 | 10,201 (0%) | 0% | 8.0 | 1,230 | Common Stock |
| Shake Shack Inc (Class A) | Jeffrey Flug | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.09 per share. | 17 Jul 2024 | 152 | 3,651 (0%) | 0% | 90.1 | 13,693 | CLASS A COMMON STOCK |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 183.49 per share. | 17 Jul 2024 | 150 | 413,893 (0%) | 0% | 183.5 | 27,524 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 183.49 per share. | 17 Jul 2024 | 150 | 413,892 (0%) | 0% | 183.5 | 27,524 | Class A Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.36 per share. | 17 Jul 2024 | 150 | 3,015,758 (5%) | 0% | 157.4 | 23,604 | Common Stock |
| Paycom | Chad Richison | Director, CEO, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.36 per share. | 17 Jul 2024 | 150 | 3,592,849 (6%) | 0% | 157.4 | 23,604 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 337.34 per share. | 17 Jul 2024 | 149 | 130 (0%) | 0% | 337.3 | 50,264 | Common Stock |
| Immunovant Inc | Mark S. Levine | Chief Legal Officer | 17 Jul 2024 | 147 | 337,409 (0%) | 0% | 30.6 | 4,491 | Common Stock | |
| Immunovant Inc | William L. Macias | Chief Medical Officer | 17 Jul 2024 | 147 | 371,894 (0%) | 0% | 30.6 | 4,491 | Common Stock | |
| Morgan Stanley | Robert H. Herz | Director | Sale of securities on an exchange or to another person at price $ 106.63 per share. | 17 Jul 2024 | 139 | 95,907 (0%) | 0% | 106.6 | 14,822 | Common Stock |
| Unifirst Corp | Cecilia K. McKenney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 136 | 136 (0%) | 0% | 0 | Common Stock | |
| Virgin Galactic Holdings Inc (Class A) | Sarah E. Kim | EVP, CLO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Jul 2024 | 115 | 9,723 (0%) | 0% | 8.0 | 925 | Common Stock |
| Esperion Therapeutics Inc | Eric Warren | Chief Commercial Officer | 17 Jul 2024 | 108 | 165,478 (0%) | 0% | 2.6 | 279 | Common Stock | |
| Alignment Healthcare Inc | Joseph Konowiecki | Director | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Jul 2024 | 100 | 1,208,221 | - | 10.0 | 1,001 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.